VIELA BIO, INC. (VIE): Price and Financial Metrics
VIE Price/Volume Stats
| Current price | $53.01 | 52-week high | $65.00 |
| Prev. close | $53.01 | 52-week low | $25.02 |
| Day low | $52.99 | Volume | 1,246,700 |
| Day high | $53.04 | Avg. volume | 1,065,058 |
| 50-day MA | $46.07 | Dividend yield | N/A |
| 200-day MA | $39.52 | Market Cap | 2.91B |
VIE Stock Price Chart Interactive Chart >
VIELA BIO, INC. (VIE) Company Bio
Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD.
VIE Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VIE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 6.60% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 32.49% |